Stocks and Investing Stocks and Investing
Wed, April 19, 2023

Matthew Sykes Maintained (TWST) at Hold with Decreased Target to $20 on, Apr 19th, 2023


Published on 2024-10-28 02:52:25 - WOPRAI, Matthew Sykes
  Print publication without navigation


Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Decreased Target from $43 to $20 on, Apr 19th, 2023.

Matthew has made no other calls on TWST in the last 4 months.



There are 4 other peers that have a rating on TWST. Out of the 4 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Matthew


  • Catherine Ramsey of "Baird" Maintained at Buy with Decreased Target to $29 on, Monday, February 6th, 2023
  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $32 on, Monday, February 6th, 2023
  • Sung Ji Nam of "Scotiabank" Initiated at Buy and Held Target at $33 on, Thursday, January 5th, 2023
  • Vijay Kumar of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $36 on, Tuesday, January 3rd, 2023

Contributing Sources